Liver diseases and metabolic syndrome.
- Published in:
- Journal of Gastroenterology, 2008, v. 43, n. 7, p. 509, doi. 10.1007/s00535-008-2193-6
- By:
- Publication type:
- Article
Works by Yaginuma, Reiko
Results: 4
1
2
Hepatic steatosis is a predictor of poor response to interferon α-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C
- Published in:
- Hepatology Research, 2006, v. 35, n. 1, p. 19, doi. 10.1016/j.hepres.2006.02.001
- By:
- Publication type:
- Article
3
Hepatic steatosis and skeletal muscle alterations during the COVID‐19 lockdown in a cohort of patients with chronic liver disease in Japan.
- Published in:
- Hepatology Research, 2024, v. 54, n. 3, p. 272, doi. 10.1111/hepr.13981
- By:
- Publication type:
- Article
4
Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial.
- Published in:
- Frontiers in Medicine, 2025, p. 1, doi. 10.3389/fmed.2025.1542741
- By:
- Publication type:
- Article